课题基金 / 基金详情

Chemical Synthesis of Novel Natural Products

Chemical Synthesis of Novel Natural Products
新型天然产物的化学合成
批准号:
6400049
负责人:
DAVID R WILLIAMS
金额:
$26.66万
依托单位国家:
美国
项目类别:
财政年份:
1982
资助国家:
美国
项目状态:
已结题
起止时间:
1982-04-01 至 2005-06-30

项目摘要

项目成果

DAVID R WILLIAMS的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (provided by applicant) - This research program is broadly directed to investigate fundamental advances for the chemical synthesis of biologically active marine natural products. Part I. Marine Antitumor Macrolides. Section A. A plan for the highly efficient, convergent, and enantiocontrolled synthesis of laulimalide will be executed. Laulimalide displays comparable potency to taxol with IC50 concentrations in the 0.01-0.05 mico/mL range against a broad selection of tumor cell lines. High cytotoxicity was registered toward KB lines (IC50 = 0.015 mico/mL). Significantly laulimalide retains activity in multi-drug resistant SKVLB-1 cultures. Section B. Strategies for the synthesis of peloruside will explore issues of stereoselectivity and efficiency for the assembly of this highly oxygenated hemiketal. With key structural features and macrocyclic rigidity, which address important proposals and research concerning the nature of the antitumor activity of the bryostatins (NCI; phase II trials), peloruside A studies are designed to offer a significant chemical advance for probing the nature of the pharmacophore and the mechanisms of biological activity for this family of molecules. Our chemical studies toward these target molecules will develop asymmetric allylation reactions. Bidirectional, divergent asymmetric allylation strategies are examined. Direct formation of new homochiral allylborane species will be pursued via cross coupling reactions with organozinc reagents. Part II. Zoanthamines. Our investigations of this novel class of marine alkaloids describe challenging issues of chemical synthesis toward densely functionalized, polycyclic systems. Members of this class have exhibited important antitumor and anti-inflammatory activities, and norzoanthamine is considered to be a promising osteoporotic candidate. Part III. Australifungin. This unique natural product is a potent antifungal which is the first nonsphingosine-based inhibitor of sphingolipid biosynthesis. It functions as a selective inhibitor of sphinganine N-acyl transferase, and may have an important role in lipid signal transduction, cell differentiation, and apoptosis. Our plans toward zoanthamines and australifungin will explore asymmetric induction in conjugate addition reactions and intramolecular Michael-based cyclizations. The intramolecular (4+2) cycloadditions of nitroalkene precursors will provide facile construction of trans-decalins. .
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
High Resolution Mapping of Foveal Ganglion Cell Receptive Fields in the Living Primate Eye
  • 批准号:
    10319191
  • 项目类别:
  • 资助金额:
    $52.47万
  • 财政年份:
    2021
  • 负责人:
    DAVID R WILLIAMS
  • 依托单位:
High Resolution Mapping of Foveal Ganglion Cell Receptive Fields in the Living Primate Eye
  • 批准号:
    10534734
  • 项目类别:
  • 资助金额:
    $55.48万
  • 财政年份:
    2021
  • 负责人:
    DAVID R WILLIAMS
  • 依托单位:
Accelerating vision restoration with in-vivo cellular imaging of retinal function
  • 批准号:
    9292320
  • 项目类别:
  • 资助金额:
    $72.37万
  • 财政年份:
    2015
  • 负责人:
    DAVID R WILLIAMS
  • 依托单位:
Accelerating vision restoration with in-vivo cellular imaging of retinal function
  • 批准号:
    9059096
  • 项目类别:
  • 资助金额:
    $71.58万
  • 财政年份:
    2015
  • 负责人:
    DAVID R WILLIAMS
  • 依托单位:
国内基金
海外基金
Iboga alkaloids骨架导向的不对称串联反应构建吖庚环并[4,5-b]吲哚及其在全合成中的应用
  • 批准号:
    21801032
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    26.0万元
  • 批准年份:
    2018
  • 负责人:
    陈惠渝
  • 依托单位: